Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope
Acute lymphoblastic leukemia (ALL) is a prevalent malignancy affecting the hematopoietic system, Dice encompassing both B-cell ALL (B-ALL) and T-cell ALL (T-ALL).T-ALL, characterized by the proliferation of T-cell progenitors in the bone marrow, presents significant treatment challenges, with patients often experiencing high relapse rates and poor